Balance Sheet 

[ XLS ]

€ million

Note

Dec. 31, 2007

Dec. 31, 2006

Current assets

 

 

 

Cash and cash equivalents

[16]

426.6

460.1

Marketable securities and financial assets

[17]

565.3

133.1

Trade accounts receivable

[18]

1,378.3

1,252.9

Inventories

[19]

1,158.5

1,218.3

Other current assets

[20]

226.4

172.1

Tax receivables

[21]

43.5

77.5

Assets held for sale

[22]

26.9

 

 

3,825.5

3,314.0

Non-current assets

 

 

 

Intangible assets

[23]

8,164.6

1,063.5

Property, plant and equipment

[24]

2,274.5

1,779.8

Investments at equity

[25]

1.4

1.3

Non-current financial assets

[25]

130.3

1,640.4

Other non-current financial assets

[20]

61.8

34.4

Deferred tax assets

[12]

464.2

269.1

 

 

11,096.8

4,788.5

 

 

 

 

Total assets

 

14,922.3

8,102.5

 

 

 

 

 

 

 

 

Current liabilities

 

 

 

Current financial liabilities

[26]

300.4

498.4

Trade accounts payable

[27]

646.9

608.0

Other current liabilities

[28]

981.3

552.3

Tax liabilities

[29]

337.1

205.5

Current provisions

[30]

297.0

201.0

Liabilities held for sale

[22]

8.0

 

 

2,570.7

2,065.2

Non-current liabilities

 

 

 

Non-current financial liabilities

[26]

1,046.6

613.6

Other non-current liabilities

[28]

39.5

7.3

Non-current provisions

[30]

570.0

284.6

Provisions for pensions and other post-employment benefits

[31]

1,185.5

1,282.3

Deferred tax liabilities

[12]

822.4

42.1

 

 

3,664.0

2,229.9

Net equity

[32]

 

 

Equity capital

 

565.2

496.6

Reserves

 

8,060.5

3,256.7

Minority interest

 

61.9

54.1

 

 

8,687.6

3,807.4

 

 

 

 

Total liabilities and stockholders’ equity

 

14,922.3

8,102.5

Last update 18.02.2008, © Merck KGaA, Darmstadt, Germany